AdvaMed® 2026 State Policy Briefing Series
Explore the 2026 State Policy Briefing Series for insights on medtech policy, legislative activity, and regulatory updates impacting the medtech industry.
AdvaMed® 2025 State Policy Briefing: EPR
Hear from Multistate policy experts Joe Rinzel and Townsend Brown as they discuss state product stewardship and producer responsibility policy trends.
AdvaMed® 2025 State Policy Briefing: PFAS
Hear from expert speakers as they give an overview of PFAS and emerging PFAS policy trends across the country.
AdvaMed® 2025 State Policy Briefing: Data Privacy
Hear from AdvaMed®’s data privacy expert, Terry Chang, on the critical exemptions in state data privacy laws across the country.
AdvaMed® 2025 State Policy Briefing: AI in Healthcare
AdvaMed®’s digital health policy expert, Geeta Pamidimukkala, and payment and health care delivery policy expert, Kirsten Tullia, break down how AI/ML technologies are transforming patient care and the FDA’s policy.
Building the Business Case for Health Access
Relive highlights from AdvaMed®’s latest Health Equity webinar, Building the Business Case for Health Equity. Discover why it’s critical for medtech organizations to prioritize equity in their business strategies.
Recruiting and Retaining Diverse Clinical Research Participants – Member Best Practices
AdvaMed® is engaged in efforts to ensure our industry is doing its part to mitigate the adverse impacts of health disparities among people and communities of color.
COVID-19 Return To Work: Managing Safety, Data And Privacy For A Secure Workplace
View presentation slides from the webinar on managing safety, data, and privacy for a secure workplace as companies return to work amid COVID-19.
Creating and Implementing a COVID-19 Return-to-Work Plan
The presentation slides include a decision-making framework for preparing to re-open offices.